Q32 Bio Inc

QTTBNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

23.7M

on 2026-06-30, from 11.9M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2026-06-25. 1 prospectus supplement filed under it since. S-3 ↗

$14.2M

Cantor Fitzgerald, agreement of 2026-04-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

4.93M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

21.4 quarters

$106.3M on 2026-06-30 ÷ $5.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-07-14	Public offering incl. 4.93M pre-funded	10,958,905	$18.25	$200.0M	424B5 ↗
2026-05-26	Private placement incl. 0.15M pre-funded	6,875,000	$8.00	$55.0M	8-K ↗
2026-02-17	Public offering incl. 1.03M pre-funded	2,692,333	not read	not read	424B5 ↗
2026-02-17	Registered direct offering incl. 1.03M pre-funded	2,051,308	$3.90	not read	8-K ↗